NewAmsterdam Pharma N.V. Earnings
NASDAQ: NAMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.50
NewAmsterdam Pharma N.V. earnings summary
NewAmsterdam Pharma N.V. is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.50. In its most recent report on Aug 5, 2026 (Q2 2026), NAMS posted EPS of $-0.52. Revenue for the quarter was $3.7 million.
Across the last 11 reports, NAMS shares moved an average of 5.6% (in either direction) in the first trading session after results, rising 4 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
NAMS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-0.52 | — | -3.5% |
| May 7, 2026 | — | $-0.40 | — | -8.5% |
| Feb 18, 2026 | — | $-0.62 | — | -0.3% |
| Nov 5, 2025 | — | $-0.61 | — | +4.3% |
| Aug 6, 2025 | — | $-0.15 | — | -0.9% |
| May 8, 2025 | — | $-0.34 | — | +2.8% |
| Feb 26, 2025 | — | $-0.91 | — | +13.3% |
| Nov 6, 2024 | — | $-0.18 | — | +3.2% |
| Aug 7, 2024 | — | $-0.41 | — | -7.8% |
| May 8, 2024 | — | $-1.06 | — | -6.3% |
| Feb 28, 2024 | — | $-0.60 | — | -10.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.